Related references
Note: Only part of the references are listed.Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
Esther H. Lips et al.
NATURE GENETICS (2022)
Risk Assessment in the Molecular Era
Christin A. Knowlton et al.
SEMINARS IN RADIATION ONCOLOGY (2022)
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
Martin Schmitt et al.
TRANSLATIONAL ONCOLOGY (2022)
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review
Renee S. J. M. Schmitz et al.
CANCERS (2022)
The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
Carole Mathelin et al.
EUROPEAN JOURNAL OF BREAST HEALTH (2022)
Cost-Effectiveness Analysis of Biological Signature DCISionRT Use for DCIS Treatment
Hayeon Kim et al.
CLINICAL BREAST CANCER (2021)
Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy
Stuart J. Schnitt
MODERN PATHOLOGY (2021)
21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma In Situ
Eileen Rakovitch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
The Clinical Utility of DCISionRT(R) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
Chirag Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804
Beryl McCormick et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Molecular Testing in Breast Cancer Current Status and Future Directions
Lulu Sun et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2021)
A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay
Rachel Y. Lei et al.
ADVANCES IN RADIATION ONCOLOGY (2021)
Role of Breast MRI in the Evaluation and Detection of DCIS: Opportunities and Challenges
Heather I. Greenwood et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)
Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy
Sheila Weinmann et al.
CLINICAL CANCER RESEARCH (2020)
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial
Birgitte V. Offersen et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cancer Outcomes in DCIS Patients Without Locoregional Treatment
Marc D. Ryser et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Management of Ductal Carcinoma In Situ (DCIS) of the Breast: Present Approaches and Future Directions
Lawrence J. Solin
CURRENT ONCOLOGY REPORTS (2019)
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
E. Shelley Hwang et al.
BMJ OPEN (2019)
The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).
Chizuko Kanbayashi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score
Kimberly J. Van Zee et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Evaluating patterns of utilization of gene signature panels and impact on treatment patterns in patients with ductal carcinoma in situ of the breast
Neal Bhutiani et al.
SURGERY (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Mortality After Invasive Second Breast Cancers Following Prior Radiotherapy for DCIS
Puyao C. Li et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ
Yan Liu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies
E. Rakovitch et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk
Troy Bremer et al.
CLINICAL CANCER RESEARCH (2018)
Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: A meta-analysis of randomized controlled trials
Pankaj Kumar Garg et al.
BREAST JOURNAL (2018)
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
Eileen Rakovitch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
Eileen Rakovitch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of PatientsWith Ductal Carcinoma In Situ
Ann C. Raldow et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study
Yasuaki Sagara et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cancer statistics: Breast cancer in situ
Elizabeth M. Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Addressing overtreatment of screen detected DCIS; the LORIS trial
Adele Francis et al.
EUROPEAN JOURNAL OF CANCER (2015)
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study
Lotte E. Elshof et al.
EUROPEAN JOURNAL OF CANCER (2015)
Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study
Lawrence J. Solin et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score result
Michael Alvarado et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
Steven A. Narod et al.
JAMA ONCOLOGY (2015)
Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
Melinda E. Sanders et al.
MODERN PATHOLOGY (2015)
Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status
Gaiane M. Rauch et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Lawrence J. Solin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Clinical Outcomes Using Accelerated Partial Breast Irradiation in Patients With Ductal Carcinoma In Situ
Chirag Shah et al.
CLINICAL BREAST CANCER (2012)
Ductal Carcinoma in Situ—The Influence of the Radiotherapy Boost on Local Control
Philip Wong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
Udo Rudloff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
Beth A. Virnig et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials
Gustavo A. Viani et al.
RADIATION ONCOLOGY (2007)
Ductal carcinoma in situ in BRCA mutation carriers
E. Shelley Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Paget's disease of the breast:: Clinical, mammographic, sonographic and pathologic findings in 52 cases
Isil Guenhan-Bilgen et al.
EUROPEAN JOURNAL OF RADIOLOGY (2006)
The natural history of ductal carcinoma in situ of the breast:: a review
B Erbas et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy - Results from the Nurses' Health Study
LC Collins et al.
CANCER (2005)
Mammography of ductal carcinoma in situ of the breast:: Review of 909 cases with radiographic-pathologic correlations
A Barreau et al.
EUROPEAN JOURNAL OF RADIOLOGY (2005)
Share Paper
